These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24286404)

  • 1. Association between salivary α-amylase activity and pain relief scale scores in cancer patients with bone metastases treated with radiotherapy.
    Liu H; Dong WY; Wang JB; Wang T; Hu P; Wei SF; Ye L; Wang QW
    Chin Med J (Engl); 2013 Dec; 126(23):4444-7. PubMed ID: 24286404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single versus conventional fractionated radiotherapy in the palliation of painful bone metastases.
    Hamouda WE; Roshdy W; Teema M
    Gulf J Oncolog; 2007 Jan; 1(1):35-41. PubMed ID: 20084712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of painful bone metastases with biphosphonates and palliative radiotherapy: a retrospective evaluation of 372 cases.
    Niang U; Kamer S; Ozsaran Z; Haydaroglu A; Kilciksiz S
    J BUON; 2009; 14(2):245-9. PubMed ID: 19650174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between salivary alpha-amylase activity and pain scale in patients with chronic pain.
    Shirasaki S; Fujii H; Takahashi M; Sato T; Ebina M; Noto Y; Hirota K
    Reg Anesth Pain Med; 2007; 32(2):120-3. PubMed ID: 17350522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22.
    Zeng L; Chow E; Bedard G; Zhang L; Fairchild A; Vassiliou V; Alm El-Din MA; Jesus-Garcia R; Kumar A; Forges F; Tseng LM; Hou MF; Chie WC; Bottomley A
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e337-42. PubMed ID: 22763028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation therapy in the management of symptomatic bone metastases: the effect of total dose and histology on pain relief and response duration.
    Arcangeli G; Giovinazzo G; Saracino B; D'Angelo L; Giannarelli D; Arcangeli G; Micheli A
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1119-26. PubMed ID: 9869238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of radiotherapy for painful bone metastases during the last 12 weeks of life: results from the Dutch Bone Metastasis Study.
    Meeuse JJ; van der Linden YM; van Tienhoven G; Gans RO; Leer JW; Reyners AK;
    Cancer; 2010 Jun; 116(11):2716-25. PubMed ID: 20225326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiotherapy for symptomatic osseous metastases: special reference to the analysis of patients achieved complete pain relief].
    Okazaki A; Nakamura Y; Noda M; Ozawa Y; Rai T; Sekine M; Maehara T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Dec; 53(12):1426-35. PubMed ID: 8108247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worst, average or current pain in the Brief Pain Inventory: which should be used to calculate the response to palliative radiotherapy in patients with bone metastases?
    Harris K; Li K; Flynn C; Chow E
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):523-7. PubMed ID: 17566723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction.
    Foro Arnalot P; Fontanals AV; Galcerán JC; Lynd F; Latiesas XS; de Dios NR; Castillejo AR; Bassols ML; Galán JL; Conejo IM; López MA
    Radiother Oncol; 2008 Nov; 89(2):150-5. PubMed ID: 18556080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party.
    Radiother Oncol; 1999 Aug; 52(2):111-21. PubMed ID: 10577696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.
    Hartsell WF; Scott CB; Bruner DW; Scarantino CW; Ivker RA; Roach M; Suh JH; Demas WF; Movsas B; Petersen IA; Konski AA; Cleeland CS; Janjan NA; DeSilvio M
    J Natl Cancer Inst; 2005 Jun; 97(11):798-804. PubMed ID: 15928300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary alpha-amylase activity: a possible indicator of pain-induced stress in orthodontic patients.
    Campos MJ; Raposo NR; Ferreira AP; Vitral RW
    Pain Med; 2011 Aug; 12(8):1162-6. PubMed ID: 21749637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary alpha-amylase activity and cortisol in horses with acute abdominal disease: a pilot study.
    Contreras-Aguilar MD; Escribano D; Martín-Cuervo M; Tecles F; Cerón JJ
    BMC Vet Res; 2018 May; 14(1):156. PubMed ID: 29747642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain flare following external beam radiotherapy and meaningful change in pain scores in the treatment of bone metastases.
    Chow E; Ling A; Davis L; Panzarella T; Danjoux C
    Radiother Oncol; 2005 Apr; 75(1):64-9. PubMed ID: 15878102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of painful bone metastases: our experience according to scientific evidence on palliative radiotherapy.
    Di Franco R; Falivene S; Ravo V; Mammucari M; Sarli E; Baffini S; De Palma G; Pepe A; Traettino M; Muto M; Cappabianca S; Muto P
    Anticancer Res; 2014 Feb; 34(2):1011-4. PubMed ID: 24511047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05).
    Roos DE; Turner SL; O'Brien PC; Smith JG; Spry NA; Burmeister BH; Hoskin PJ; Ball DL;
    Radiother Oncol; 2005 Apr; 75(1):54-63. PubMed ID: 15878101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastases.
    Kaasa S; Brenne E; Lund JA; Fayers P; Falkmer U; Holmberg M; Lagerlund M; Bruland O
    Radiother Oncol; 2006 Jun; 79(3):278-84. PubMed ID: 16793154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of health-related quality of life with the European Organization for Research and Treatment of Cancer QLQ-C15-PAL after palliative radiotherapy of bone metastases.
    Caissie A; Zeng L; Nguyen J; Zhang L; Jon F; Dennis K; Holden L; Culleton S; Koo K; Tsao M; Barnes E; Danjoux C; Sahgal A; Simmons C; Chow E
    Clin Oncol (R Coll Radiol); 2012 Mar; 24(2):125-33. PubMed ID: 21917431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Change in urinary markers of osteoclast activity following palliative radiotherapy for bone metastases.
    Chow E; Hird A; Zhang L; Sinclair E; Danjoux C; Barnes E; Tsao M; Barbera L; Wong S; Vieth R
    Clin Oncol (R Coll Radiol); 2009 May; 21(4):336-42. PubMed ID: 19250812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.